製藥業

East offers prescription for west’s plans

So many western drug companies have set up offices in Shanghai’s science park in the past few years that their employees now even have a lunch venue named in their honour: the Pharma Valley Restaurant.

While Chinese companies remain focused on their domestic market, its presence symbolises that foreign rivals are just as interested in local investment.

“No western CEO can afford not to have a China strategy,” says Xun Zhang, senior vice-president at Hutchison MediPharma, part of Hutchison Whampoa. Last month, he hosted a delegation of top executives from Merck in the US, which seeks to understand and expand in the market.

您已閱讀14%(627字),剩餘86%(3771字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×